Augustine Lawlor Net Worth

The estimated Net Worth of Augustine Lawlor is at least 11.4 百万$ dollars as of 26 January 2024. Mr. Lawlor owns over 5,000 units of Leap Therapeutics Inc stock worth over 14,088$ and over the last 16 years he sold LPTX stock worth over 10,555,988$. In addition, he makes 815,868$ as Chief Operating Officer at Leap Therapeutics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Lawlor LPTX stock SEC Form 4 insiders trading

Augustine has made over 5 trades of the Leap Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of LPTX stock worth 13,850$ on 26 January 2024.

The largest trade he's ever made was buying 1,057,769 units of Leap Therapeutics Inc stock on 14 November 2017 worth over 6,441,813$. On average, Augustine trades about 33,304 units every 56 days since 2009. As of 26 January 2024 he still owns at least 5,086 units of Leap Therapeutics Inc stock.

You can see the complete history of Mr. Lawlor stock trades at the bottom of the page.

Augustine Lawlor biography

Augustine J. Lawlor serves as Chief Operating Officer of the Company. Mr. Lawlor has been a managing director of HealthCare Ventures LLC since 2000, including serving as the chief executive officer of GITR, Inc. prior to its merger into Leap. Prior to joining HealthCare Ventures, Mr. Lawlor served as Chief Operating Officer of LeukoSite Inc., a biotechnology company, from 1997 to 1999. Before joining LeukoSite, Mr. Lawlor served as Chief Financial Officer and Vice President of Corporate Development of Alpha-Beta Technology, Inc., a biotechnology company. He was also previously Chief Financial Officer and Vice President, Business Development, of BioSurface Technologies Corporation, a biotechnology company. Mr. Lawlor serves on the board of directors of Cardiovascular Systems, Inc. (NASDAQ: CSII) and Catalyst Biosciences, Inc. (NASDAQ: CBIO), each a publicly-traded biopharmaceutical company, and a number of private companies. He received a B.A. from the University of New Hampshire and a master's degree in management from Yale University.

What is the salary of Augustine Lawlor?

As the Chief Operating Officer of Leap Therapeutics Inc, the total compensation of Augustine Lawlor at Leap Therapeutics Inc is 815,868$. There are 1 executives at Leap Therapeutics Inc getting paid more, with Douglas Onsi having the highest compensation of 816,959$.

How old is Augustine Lawlor?

Augustine Lawlor is 64, he's been the Chief Operating Officer of Leap Therapeutics Inc since 2016. There are 3 older and 7 younger executives at Leap Therapeutics Inc. The oldest executive at Leap Therapeutics Inc is James Cavanaugh, 82, who is the Independent Director.

What's Augustine Lawlor's mailing address?

Augustine's mailing address filed with the SEC is C/O LEAP THERAPEUTICS, INC., 47 THORNDIKE STREET SUITE B1-1, CAMBRIDGE, MA, 02141.

Insiders trading at Leap Therapeutics Inc

Over the last 8 years, insiders at Leap Therapeutics Inc have traded over 0$ worth of Leap Therapeutics Inc stock and bought 10,810,588 units worth 40,517,079$ . The most active insiders traders include Advisors Llcperceptive Life...、Christopher Mirabelli、Ltd. Bei Gene,. On average, Leap Therapeutics Inc executives and independent directors trade stock every 142 days with the average trade being worth of 1,990,710$. The most recent stock trade was executed by Christopher Mirabelli on 26 January 2024, trading 5,000 units of LPTX stock currently worth 13,850$.

What does Leap Therapeutics Inc do?

leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.

Complete history of Mr. Lawlor stock trades at Cardiovascular Systems、Catalyst Biosciences Inc、Leap Therapeutics Inc

Leap Therapeutics Inc executives and stock owners

Leap Therapeutics Inc executives and other stock owners filed with the SEC include:

• Douglas Onsi,
  President, Chief Executive Officer, Director
• Augustine Lawlor,
  Chief Operating Officer
• Christopher Mirabelli,
  Chairman of the Board
• Cynthia Sirard,
  Chief Medical Officer
• Mark O'Mahony,
  Chief Manufacturing Officer
• Nissim Mashiach,
  Independent Director
• Joseph Loscalzo,
  Independent Director
• William Li,
  Independent Director
• Thomas Dietz,
  Lead Independent Director
• James Cavanaugh,
  Independent Director
• Monica Bertagnolli,
  Independent Director
• John W Littlechild,
  Director
• Ventures Ix, L.P.Healthcare...,
  
• Harold R Werner,
  10% owner
• Lilly & Co Eli,
  10% owner
• Patricia A. Martin,
  Director
• Christian M Richard,
  Director
• Richard Schilsky,
  Director
• Advisors Llcperceptive Life...,
  
• Ventures Viii, L.P.Health C...,
  
• Jason Baum,
  Chief Scientific Officer
• Christine Granfield,
  VP, Head of Reg Affairs/Qual
• Ltd. Bei Gene,,
  10% owner